Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study. [electronic resource]
Producer: 19980616Description: 641-8 p. digitalISSN:- 0149-5992
- Adult
- Aged
- Bezafibrate -- therapeutic use
- Carotid Arteries -- diagnostic imaging
- Cholesterol -- blood
- Cholesterol, HDL -- blood
- Coronary Disease -- diagnosis
- Diabetes Mellitus, Type 2 -- blood
- Diabetic Angiopathies -- diagnosis
- Double-Blind Method
- Electrocardiography
- Exercise Test
- Female
- Femoral Artery -- diagnostic imaging
- Fibrinogen -- analysis
- Follow-Up Studies
- Humans
- Hypolipidemic Agents -- therapeutic use
- Lipids -- blood
- Lipoproteins -- blood
- Male
- Middle Aged
- Placebos
- Time Factors
- Triglycerides -- blood
- Ultrasonography
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.